Related Experiment Video
Updated: Aug 11, 2026

An Experimental Paradigm for the Prediction of Post-Operative Pain (PPOP)
Published on: January 27, 2010
Application of information theory to decision analysis in potentially prostaglandin-responsive neonates
Insights
Prostaglandin E1 therapy can benefit neonates with suspected heart disease. Early treatment is recommended for cyanotic infants with murmurs or poor pulses, while acyanotic infants with normal pulses should wait for diagnosis.
Area of Science:
- Pediatric Cardiology
- Neonatal Medicine
- Medical Informatics
Background:
- Neonates with suspected heart disease often require transfer to tertiary care centers.
- The use of prostaglandin E1 (PGE1) can be crucial for managing certain congenital heart defects.
- Predicting PGE1 responsiveness is vital for optimizing treatment decisions.
Purpose of the Study:
- To identify clinical variables that predict a favorable response to PGE1 in neonates with suspected heart disease.
- To define optimal settings for initiating PGE1 therapy before inter-facility transfer.
- To utilize information theory and decision analysis for improved clinical decision-making.
Main Methods:
- Reviewed records of 250 neonates (0-7 days old) with suspected heart disease.
- Assessed six clinical variables: cyanosis, respiratory distress, heart murmur, pulse contour, hepatomegaly, and prematurity.
- Applied information theory to quantify the predictive value of each variable for PGE1 responsiveness, using Bayes' rule for probability estimation.
Main Results:
- Cyanosis, murmur, small volume pulses, and prematurity were identified as informative variables for predicting PGE1-responsive defects.
- Decision analysis suggested early PGE1 treatment for cyanotic term infants with murmurs or poor pulses.
- Acyanotic neonates with normal pulses were best treated with PGE1 only after definitive diagnosis.
Conclusions:
- Information theory and decision analysis provide a rigorous framework for identifying key clinical predictors of PGE1 response in neonates.
- Early PGE1 intervention is beneficial for specific high-risk neonates, guiding treatment decisions during transfer.
- This approach helps optimize the use of PGE1, improving outcomes for neonates with critical congenital heart disease.
Abstract:
To define settings in which use of prostaglandin E1 before transfer from a community hospital to a tertiary care center benefits neonates with possible heart disease, information theory was used to predict the probability of a favorable response to prostaglandin therapy from the limited information of clinical variables. Records of 250 patients, newborn to 7 days old, with suspected heart disease were reviewed to assess six clinical variables (cyanosis, respiratory distress, heart murmur, pulse contour, hepatomegaly and prematurity). According to the anatomic and hemodynamic cardiovascular condition, each case was categorized as to whether a favorable response to prostaglandin E1 could be anticipated. Information content of each clinical variable with respect to prostaglandin responsiveness was determined, and patients were classified according to the most informative clinical variable. Stepwise extraction of information proceeded until remaining clinical variables added no significant information. Bayes' rule gave estimates of probability of prostaglandin-responsive defect in final subgroups for use in decision analysis. Cyanosis, murmur, small volume pulses and prematurity gave information about prostaglandin-responsive defects. Decision analysis indicated that frequency of poor outcome is minimized by early prostaglandin treatment of cyanotic term infants with a murmur or poor pulses, regardless of how ill they appear, and by treating any critically ill term newborn who has either cyanosis or poor pulses. Acyanotic patients with normal pulses are best untreated with prostaglandin until after definitive diagnosis is made. Advantage to either course was not seen in some small subgroups. Information theory with decision analysis is a rigorous approach to identify relevant clinical variables and define their roles in critical decisions in pediatric cardiology.

